Mechanisms in endocrinology: Vitamin D as a potential contributor in endocrine health and disease

European Journal of Endocrinology

Volumn 171, Issue 3, 2014, Pages R101-R110

  Muscogiuri, Giovanna ^a   Mitri, Joanna ^b   Mathieu, Chantal ^c   Badenhoop, Klaus ^d   Tamer, Gonca ^e   Orio, Francesco ^f,g   Mezza, Teresa ^h   Vieth, Reinhold ^i,j   Colao, Annamaria ^a   Pittas, Anastassios ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^f UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^g UNIVERSITY HOSPITAL SAN GIOVANNI DI DIO E RUGGI D ARAGONA   (Italy)

^h CATHOLIC UNIVERSITY   (Italy)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; COLECALCIFEROL; OMEGA 3 FATTY ACID; PARATHYROID HORMONE; VITAMIN D;

ADDISON DISEASE; AUTOIMMUNE THYROIDITIS; DISEASE ASSOCIATION; DRUG MEGADOSE; ENDOCRINE DISEASE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRIMARY HYPERPARATHYROIDISM; REVIEW; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; ANIMAL; BLOOD; ENDOCRINOLOGY; FEMALE; HEALTH STATUS; HYPERPARATHYROIDISM; METHODOLOGY;

ANIMALS; ENDOCRINE SYSTEM DISEASES; ENDOCRINOLOGY; FEMALE; GRAVES DISEASE; HEALTH STATUS; HUMANS; HYPERPARATHYROIDISM; POLYCYSTIC OVARY SYNDROME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84907188253     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0158     Document Type: Review

References (80)

1. EURODIAB Study Group. Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy
2. Study Group. Diabetologia 1999 42 51-54. (doi:10.1007/s001250051112)
3. Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE & Hu FB. Blood 25-hydroxy vitamin D levels and incident type diabetes: a meta-analysis of prospective studies. Diabetes Care 2013 36 1422-1428. (doi:10.2337/dc12-0962)
4. Afzal S, Bojesen SE & Nordestgaard BG. Low 25-hydroxyvitamin D and risk of type diabetes: a prospective cohort study and metaanalysis. Clinical Chemistry 2013 59 381-391. (doi:10.1373/clinchem.2012. 193003)
5. Tamer G, Arik S, Tamer I & Coksert D. Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid 2011 21 891-896. (doi:10.1089/thy. 2009.0200)
6. Lopez ER, Zwermann O, Segni M, Meyer G, Reincke M, Seissler J, Herwig J, Usadel KH & Badenhoop K. A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. European Journal of Endocrinology 2004 151 193-197. (doi:10.1530/eje.0. 1510193)
7. Holick MF. Vitamin D deficiency. New England Journal of Medicine 2007 357 266-281. (doi:10.1056/NEJMra070553)
8. Lips P. Vitamin D physiology. Progress in Biophysics and Molecular Biology 2006 92 4-8. (doi:10.1016/j.pbiomolbio.2006.02.016)
9. Dietary Reference Intakes for Calcium and Vitamin D-Institute of Medicine of National Academies- November 30, 2010.
10. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM & Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2011 96 1911-1930. (doi:10.1210/jc.2011-0385)
11. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. New England Journal of Medicine 2013 369 1991-2000. (doi:10.1056/NEJMoa1306357)
12. Segersten U, Correa P, Hewison M, Hellman P, Dralle H, Carling T, Akerström G & Westin G. 25-Hydroxyvitamin D(3)-1a-hydroxylase expression in normal and pathological parathyroid glands. Journal of Clinical Endocrinology and Metabolism 2002 87 2967-2972.
13. Souberbielle JC, BienaiméF, Cavalier E & Cormier C. Vitamin D and primary hyperparathyroidism (PHPT). Annales d'Endocrinologie 2012 73 165-169. (doi:10.1016/j.ando.2012.04.008)
14. Cusano NE, Silverberg SJ & Bilezikian JP. Normocalcemic primary hyperparathyroidism. Journal of Clinical Densitometry 2013 16 33-39. (doi:10.1016/j.jocd.2012.12.001)
15. Amir E, Simmons CE, Freedman OC, Dranitsaris G, Cole DE, Vieth R, OoiWS & Clemons M. A phase 2 trial exploring the effects of high-dose (10, 000 IU/day) vitamin D(3) in breast cancer patients with bone metastases. Cancer 2010 116 284-291. (doi:10.1002/cncr.24749)
16. Atkinson MA. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harbor Perspectives in Medicine 2012 2. (doi:10.1101/cshperspect.a007641)
17. Wolden-Kirk H, Gysemans C, Verstuyf A & Mathieu C. Extraskeletal effects of vitamin D. Endocrinology and Metabolism Clinics of North America 2012 41 571-594. (doi:10.1016/j.ecl.2012.05.004)
18. Giulietti A, Gysemans C, Stoffels K, van Etten E, Decallonne B, Overbergh L, Bouillon R & Mathieu C. Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia 2004 47 451-462. (doi:10.1007/s00125-004-1329-3)
19. Gysemans C, van Etten E, Overbergh L, Giulietti A, Eelen G, Waer M, Verstuyf A, Bouillon R & Mathieu C. Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor. Diabetes 2008 57 269-275.
20. Wolden-Kirk H, Rondas D, Bugliani M, Korf H, Van Lommel L, Brusgaard K, Christesen HT, Schuit F, Proost P, MasiniMet al. Discovery of molecular pathways mediating 1, 25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans. Endocrinology 2014 155 736-747.
21. Korf H, Wenes M, Stijlemans B, Takiishi T, Robert S, Miani M, Eizirik DL, Gysemans C & Mathieu C. 1, 25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology 2012 217 1292-1300. (doi:10.1016/j.imbio.2012.07.018REF17Z10.1007/s00125-004-1329-3)
22. Mathieu C, Waer M, Laureys J, Rutgeerts O & Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1, 25 dihydroxyvitamin D3. Diabetologia 1994 37 552-558. (doi:10.1007/BF00403372)
23. Zella JB, McCary LC & DeLuca HF. Oral administration of 1, 25- dihydroxyvitamin D3 completely protects NOD mice from insulindependent diabetes mellitus. Archives of Biochemistry and Biophysics 2003 417 77-80. (doi:10.1016/S0003-9861(03)00338-2)
24. Takiishi T, Ding L, Baeke F, Spagnuolo I, Sebastiani G, Laureys J, Verstuyf A, Carmeliet G, Dotta F, Van Belle TL et al. Dietary supplementation with high doses of regular vitamin D3 safely reduces diabetes incidence in nod mice when given early and long-term. Diabetes 2014 63 2026-2036. (doi:10.2337/db13-1559)
25. Casteels KM, Mathieu C, Waer M, Valckx D, Overbergh L, Laureys JM& Bouillon R. Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1, 25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A. Endocrinology 1998 139 95-102. (doi:10.1210/endo. 139.1.5641)
26. Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC & Adorini L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. Journal of Immunology 2004 173 2280-2287. (doi:10.4049/jimmunol.173.4.2280)
27. Takiishi T, Van Belle T, Gysemans C & Mathieu C. Effects of vitamin D on antigen-specific and non-antigen-specific immune modulation: relevance for type 1 diabetes. Pediatric Diabetes 2013 14 81-89. (doi:10.1111/j.1399-5448.2012.00923.x)
28. Nikolic T & Roep BO. Regulatory multitasking of tolerogenic dendritic cells - lessons taken from vitamin D3-treated tolerogenic dendritic cells. Frontiers in Immunology 2013 4 113. (doi:10.3389/fimmu.2013.00113)
29. Ferreira GB, Gysemans CA, Demengeot J, da Cunha JP, Vanherwegen AS, Overbergh L, Van Belle TL, Pauwels F, Verstuyf A, Korf H et al. 1, 25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice. Journal of Immunology 2014 192 4210-4220. (doi:10.4049/jimmunol.1302350)
30. Borkar VV, Devidayal V, Verma S & Bhalla AK. Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes. Pediatric Diabetes 2010 11 345-350. (doi:10.1111/j.1365-2265.2004. 02015.x)
31. Pozzilli P, Manfrini S, Crinò A, Picardi A, Leomanni C, Cherubini V, Valente L, Khazrai M, Visalli N & IMDIAB group . Low levels of 25-hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Hormone and Metabolic Research 2005 37 680-683. (doi:10.1055/s-2005-870578)
32. Littorin B, Blom P, Schölin A, Arnqvist HJ, BlohméG, Bolinder J, Ekbom-Schnell A, Eriksson JW, Gudbjörnsdottir S, Nyström L et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006 49 2847-2852. (doi:10.1007/s00125- 006-0426-x)
33. Cooper JD, Smyth DJ, Walker NM, Stevens H, Burren OS, Wallace C, Greissl C, Ramos-Lopez E, Hyppönen E, Dunger DB et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011 60 1624-1631. (doi:10.2337/db10-1656)
34. Svoren BM, Volkening LK, Wood JR & Laffel LM. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. Journal of Pediatrics 2009 154 132-134. (doi:10.1016/j.jpeds.2008.07.015)
35. Greer RM, Rogers MA, Bowling FG, Buntain HM, Harris M, LeongGM & Cotterill AM. Australian children and adolescents with type 1 diabetes have low vitamin D levels. Medical Journal of Australia 2007 187 59-60.
36. Bener A, Alsaied A, Al-Ali M, Al-Kubaisi A, Basha B, Abraham A, Guiter G & Mian M. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetologia 2009 46 183-189. (doi:10.1007/s00592-008-0071-6)
37. Frederiksen BN, Kroehl M, Fingerlin TE, Wong R, Steck AK, Rewers M & Norris JM. Association between vitamin D metabolism gene polymorphisms and risk of islet autoimmunity and progression to type 1 diabetes: the diabetes autoimmunity study in the young (DAISY). Journal of Clinical Endocrinology and Metabolism 2013; 98: E1845-E1851. (doi:10.1210/jc.2013-2256)
38. Stene LC, Joner G & Norwegian Childhood Diabetes Study Group. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case- control study. American Journal of Clinical Nutrition 2003 78 1128-1134.
39. Hypponen E, Laara E, Reunanen A, Jarvelin MR & Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth cohort study. Lancet 2001 358 1500-1503. (doi:10.1016/S0140-6736(01)06580-1)
40. Stene LC, Ulriksen J, Magnus P & Joner G. Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring. Diabetologia 2000 43 1093-1098. (doi:10.1007/s001250051499)
41. Brekke HK & Ludvigsson J. Vitamin D supplementation and diabetesrelated autoimmunity in the ABIS study. Pediatric Diabetes 2007 8 11-14. (doi:10.1111/j.1399-5448.2006.00223.x)
42. Walter M, Kaupper T, Adler K, Foersch J, Bonifacio E & Ziegler AG. No effect of the 1a, 25-dihydroxyvitamin D3 on b-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care 2010 33 1443-1448. (doi:10.2337/dc09-2297)
43. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R & Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB Journal 2003 17 509-511.
44. Maestro B, Davila N, CarranzaMC & Calle C. Identification of a vitamin D response element in the human insulin receptor gene promoter. Journal of Steroid Biochemistry and Molecular Biology 2003 84 223-230. (doi:10.1016/S0960-0760(03)00032-3)
45. Bizzarri C, Pitocco D, Napoli N, Di Stasio E, Maggi D, Manfrini S, Suraci C, Cavallo MG, Cappa M, Ghirlanda G et al. No protective effect of calcitriol on b-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care 2010 33 1962-1963. (doi:10.2337/dc10-0814)
46. Milner RD & Hales CN. The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia 1967 3 47-49. (doi:10.1007/BF01269910)
47. Wright DC, Hucker KA, Holloszy JO & Han DH. Ca2C and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes 2004 53 330-335. (doi:10.2337/diabetes.53.2.330)
48. Avenell A, Cook JA, MacLennan GS & McPherson GC. Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age and Ageing 2009 38 606-609. (doi:10.1093/ageing/afp109)
49. Mitri J, Dawson-Hughes B, Hu FB & Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic b cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. American Journal of Clinical Nutrition 2011 94 486-494. (doi:10. 3945/ajcn.111.011684)
50. Davidson MB, Duran P, Lee ML & Friedman TC. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013 36 260-266. (doi:10.2337/dc12-1204)
51. Bratland E & Husebye ES. Cellular immunity and immunopathology in autoimmune Addison's disease. Molecular and Cellular Endocrinology 2011 336 180-190. (doi:10.1016/j.mce.2010.12.015)
52. Skinningsrud B, Lie BA, Lavant E, Carlson JA, Erlich H, Akselsen HE, Gervin K, Wolff AB, Erichsen MM, Lovas K et al. Multiple loci in the HLA complex are associated with Addison's disease. Journal of Clinical Endocrinology and Metabolism 2011; 96: E1703-E1708. (doi:10.1210/jc. 2011-0645)
53. Pani MA, Seissler J, Usadel KH & Badenhoop K. Vitamin D receptor genotype is associated with Addison's disease. European Journal of Endocrinology 2002 147 635-640.
54. Fichna M, Zurawek M, Januszkiewicz-Lewandowska D, Gryczynska M, Fichna P, Sowinski J & Nowak J. Association of the CYP27B1 C(K1260)A polymorphism with autoimmune Addison's disease. Experimental and Clinical Endocrinology & Diabetes 2010 118 544-549. (doi:10.1055/s-0029-1241206)
55. Lundqvist J, Norlin M & Wikvall K. 1a, 25-Dihydroxyvitamin D3 affects hormone production and expression of steroidogenic enzymes in human adrenocortical NCI-H295R cells. Biochimica et Biophysica Acta 2010 1801 1056-1062. (doi:10.1016/j.bbalip.2010.04.009)
56. Szyper-Kravitz M, Marai I & Shoenfeld Y. Coexistence of thyroid autoimmunity with other autoimmune diseases: friend or foe? Additional aspects on the mosaic of autoimmunity Autoimmunity 2005 38 247-255. (doi:10.1080/08916930500050194)
57. Volpe R. Autoimmune thyroiditis. In Werner and Ingbar's the Thyroid, 6th edn, pp 921-941. Eds LE Braverman & RD Utiger. Philadelphia: JB Lippincott Co., 1991.
58. Bozkurt NC, Karbek B, Ucan B, SahinM, Cakal E, OzbekM& Delibaşi T. The association between severity of vitamin D deficiency and Hashimoto's thyroiditis. Endocrine Practice 2013 19 479-484. (doi:10. 4158/EP12376.OR)
59. Tamer G & Mesci B. Role of vitamin D in the immune system. Turkish Journal of Endocrinology and Metabolism 2013 17 5-7. (doi:10.4274/Tjem.1938)
60. Camurdan OM, Döʇer E, Bideci A, Celik N & Cinaz P. Vitamin D status in children with Hashimoto thyroiditis. Journal of Pediatric Endocrinology & Metabolism 2012 25 467-470. (doi:10.1515/jpem-2012-0021)
61. Kivity S, Agmon Levin N, Zisappl M, Shapira Y, Nagy EV, Dankó K, Szekanecz Z, Langevitz P & Shoenfeld Y. Vitamin D and autoimmune thyroid diseases. Cellular & Molecular Immunology 2011 8 243-247. (doi:10.1038/cmi.2010.73)
62. Yazici D, Yavuz D, Tarcin O, Sancak S, Deyneli O & Akalin S. Vitamin D receptor gene ApaI, TaqI and BsmI polimorphism in a group of Turkish patients with Hashimoto's thyroiditis. Minerva Endocrinologica 2013 38 195-201.
63. Lacka K & Maciejewski A. Vitamin D in the etiopathogenesis of autoimmune thyroiditis. Polski Merkuriusz Lekarski 2013 34 281-285.
64. Christakos S, Raval-Pandya M, Wernyj RP & Yang W. Genomic mechanisms involved in the pleiotropic actions of 1, 25-dihydroxyvitamin D3. Biochemical Journal 1996 316 361-371.
65. Baeke F, Takiishi T, Korf H, Gysemans C & Mathieu C. Vitamin D: modulator of the immune system. Current Opinion in Pharmacology 2010 10 482-496. (doi:10.1016/j.coph.2010.04.001)
66. Ban Y, Ban Y, Taniyama M & Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 2000 10 475-480.
67. Ban Y, TaniyamaM& Ban Y. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. Journal of Clinical Endocrinology and Metabolism 2000 85 4639-4643. (doi:10.1210/jcem.87.6.8604)
68. Collins JE, Heward JM, Nithiyananthan R, Nejentsev S, Todd JA, Franklyn JA & Gough SC. Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians. Clinical Endocrinology 2004 60 618-624. (doi:10.1111/j.1365-2265.2004.02015.x)
69. Feng M, Li H, Chen SF, Li WF & Zhang FB. Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis. Endocrine 2013 43 318-326. (doi:10.1007/s12020-012- 9812-y)
70. Yasuda T, Okamoto Y, Hamada N, Miyashita K, Takahara M, Sakamoto F, Miyatsuka T, Kitamura T, Katakami N, Kawamori D et al. Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves' disease. Endocrine 2012 42 739-741. (doi:10.1007/s12020-012-9679-y)
71. Yasuda T, Okamoto Y, Hamada N, Miyashita K, Takahara M, Sakamoto F, Miyatsuka T, Kitamura T, Katakami N, Kawamori D et al. Serum vitamin D levels are decreased in patients without remission of Graves' disease. Endocrine 2013 43 230-232. (doi:10.1007/s12020-012- 9789-6)
72. Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, Kimmig R, Mann K & Janssen OE. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Experimental and Clinical Endocrinology & Diabetes 2006 114 577-583. (doi:10.1055/s-2006- 948308)
73. Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR & Obermayer-Pietsch B. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. European Journal of Endocrinology 2009 161 575-582. (doi:10.1530/EJE-09-0432)
74. Ott J, Wattar L, Kurz C, Seemann R, Huber JC, Mayerhofer K & Vytiska-Binstorfer E. Parameters for calcium metabolism in women with polycystic ovary syndrome who undergo clomiphene citrate stimulation: a prospective cohort study. European Journal of Endocrinology 2012 166 897-902. (doi:10.1530/EJE-11-1070)
75. Thys-Jacobs S, Donovan D, Papadopoulos A, Sarrel P & Bilezikian JP. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids 1999 64 430-435. (doi:10.1016/S0039- 128X(99)00012-4)
76. Wehr E, Pieber TR & Obermayer-Pietsch B. Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study. Journal of Endocrinological Investigation 2011 34 757-763. (doi:10.3275/7748)
77. Glintborg D, Andersen M, Hagen C & Hermann AP. Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism. Clinical Endocrinology 2005 62 683-691. (doi:10.1111/j.1365- 2265.2005.02280.x)
78. Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG & Kamaci M. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Archives of Gynecology and Obstetrics 2009 280 559-563. (doi:10.1007/s00404-009- 0958-7)
79. Muscogiuri G, Policola C, Prioletta A, Sorice G, Mezza T, Lassandro A, Della Casa S, Pontecorvi A & Giaccari A. Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? Clinical Nutrition 2012 31 476-480. (doi:10.1016/j.clnu.2011.12.010)
80. Kotsa K, Yavropoulou MP, Anastasiou O & Yovos JG. Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertility and Sterility 2009 92 1053-1058. (doi:10.1016/j.fertnstert. 2008.07.1757)